Eterna Therapeutics's market cap is currently ―. The company's EPS TTM is $-4.08; its P/E ratio is -0.44; Eterna Therapeutics is scheduled to report earnings on April 14, 2023, and the estimated EPS forecast is $-2.40. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 51.00K	$ 21.00K	$ 21.00K	$ 42.00K	$ 0.00
Gross Profit	$ -69.00K	$ 21.00K	$ 21.00K	$ 42.00K	-
EBIT	$ -5.60M	$ -4.50M	$ -5.41M	$ -4.73M	$ -7.30M
EBITDA	$ -5.03M	-	$ -5.35M	$ -4.65M	$ -7.18M
Net Income Common Stockholders	$ -5.59M	$ -4.52M	$ -5.42M	$ -4.50M	$ -7.32M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 4.55M	$ 1.84M	$ 5.40M	$ 11.45M	$ 13.25M
Total Assets	$ 52.25M	$ 46.95M	$ 15.11M	$ 22.28M	$ 20.93M
Total Debt	$ 39.60M	$ 35.14M	$ 1.01M	$ 1.18M	$ 2.76M
Net Debt	$ 35.05M	$ 33.30M	$ -4.39M	$ -10.26M	$ -10.49M
Total Liabilities	$ 48.69M	$ 43.09M	$ 7.73M	$ 10.17M	$ 12.11M
Stockholders Equity	$ 3.56M	$ 3.87M	$ 7.38M	$ 12.11M	$ 8.81M
Cash Flow	-
Free Cash Flow	$ -5.80M	-	$ -6.03M	$ -5.32M	$ -6.16M
Operating Cash Flow	$ -5.80M	$ -3.90M	$ -6.03M	$ -5.50M	$ -6.12M
Investing Cash Flow	-	-	-	$ 129.00K	$ -43.00K
Financing Cash Flow	$ 8.54M	$ 312.00K	-	$ 7.59M	$ 6.00K

Currency in USD

Eterna Therapeutics Earnings and Revenue History

Income Statement >

Eterna Therapeutics Debt to Assets

Balance Sheet >

Eterna Therapeutics Cash Flow

Cash Flow >

Eterna Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing